June 5, 2019 Price forecast | 2 weeks: 6.14% | 1 month: 5.78% | 3 months: 14.01% | Premium Forecast


NAVB stock forecast

Our latest prediction for Navidea Biopharmaceuticals, Inc.'s stock price was made on the June 5, 2019 when the stock price was at 1.23$.

In the short term (2weeks), NAVB's stock price should outperform the market by 6.14%. During that period the price should oscillate between -12.05% and +27.75%.

In the medium term (3months), NAVB's stock price should outperform the market by 14.01%. During that period the price should oscillate between -24.15% and +66.56%.


About Navidea Biopharmaceuticals, Inc.

Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH.

At the moment the company generates 1M USD in revenues.

On its last earning announcement, the company reported a loss of -0.84$ per share.

The book value per share is 0.01$

Navidea Biopharmaceuticals, Inc. website


Three months stock forecastJune 5, 2019


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
1M 95.50% -10M -927.60% -11M -0.84 - - 12M 0.01 -9M - -9M